Fate Therapeutics (FATE) Short Interest Ratio & Short Volume $1.14 -0.01 (-0.87%) Closing price 07/14/2025 04:00 PM EasternExtended Trading$1.19 +0.05 (+4.47%) As of 07:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Fate Therapeutics Short Interest DataFate Therapeutics (FATE) has a short interest of 9.54 million shares, representing 8.81% of the float (the number of shares available for trading by the public). This marks a 0.32% increase in short interest from the previous month. The short interest ratio (days to cover) is 4.7, indicating that it would take 4.7 days of the average trading volume of 2.21 million shares to cover all short positions.Current Short Interest9,540,000 sharesPrevious Short Interest9,510,000 sharesChange Vs. Previous Month+0.32%Dollar Volume Sold Short$10.68 millionShort Interest Ratio4.7 Days to CoverLast Record DateJune 30, 2025Outstanding Shares114,600,000 sharesShort Percent of Float8.81%Today's Trading Volume1,219,455 sharesAverage Trading Volume2,211,027 sharesToday's Volume Vs. Average55% Short Selling Fate Therapeutics? Sign up to receive the latest short interest report for Fate Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFATE Short Interest Over TimeFATE Days to Cover Over TimeFATE Percentage of Float Shorted Over Time Fate Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/20259,540,000 shares $10.68 million +0.3%8.8%4.7 $1.12 6/15/20259,510,000 shares $12.13 million -13.9%8.8%4.6 $1.28 5/31/202511,050,000 shares $13.65 million -14.1%10.2%5.5 $1.24 5/15/202512,870,000 shares $13.00 million -3.5%11.9%5.9 $1.01 4/30/202513,340,000 shares $17.08 million -14.4%N/A5.6 $1.28 4/15/202515,590,000 shares $17.46 million -4.8%14.4%6.8 $1.12 3/31/202516,370,000 shares $12.93 million +12.4%15.1%7 $0.79 3/15/202514,570,000 shares $13.72 million +9.3%13.5%5.8 $0.94 2/28/202513,330,000 shares $14.93 million +2.1%12.3%4.8 $1.12 2/15/202513,060,000 shares $18.55 million +1.5%12.1%4.4 $1.42 Get the Latest News and Ratings for FATE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202512,870,000 shares $16.73 million +1.3%N/A4.2 $1.30 1/15/202512,700,000 shares $16.76 million +13.4%N/A4.1 $1.32 12/31/202411,200,000 shares $18.48 million -8.1%N/A3.8 $1.65 12/15/202412,190,000 shares $22.31 million +7.4%N/A4.5 $1.83 11/30/202411,350,000 shares $35.98 million +9.2%N/A5 $3.17 11/15/202410,390,000 shares $20.99 million -34.7%N/A5.4 $2.02 10/31/202415,900,000 shares $37.68 million -1.0%N/A12.6 $2.37 10/15/202416,060,000 shares $48.98 million +13.3%N/A12.2 $3.05 9/30/202414,180,000 shares $49.63 million -5.7%N/A8.8 $3.50 9/15/202415,040,000 shares $60.46 million -0.9%N/A9.2 $4.02 8/31/202415,170,000 shares $55.67 million +8.9%N/A8.1 $3.67 8/15/202413,930,000 shares $47.22 million +0.9%N/A6.8 $3.39 7/31/202413,800,000 shares $73.55 million -32.0%N/A6.1 $5.33 7/15/202420,290,000 shares $78.93 million +2.1%N/A8.3 $3.89 6/30/202419,870,000 shares $65.17 million -6.1%N/A8.5 $3.28 6/15/202421,150,000 shares $76.35 million -5.3%N/A8.7 $3.61 5/31/202422,340,000 shares $82.21 million +7.4%N/A8.8 $3.68 5/15/202420,810,000 shares $88.23 million -6.0%N/A8 $4.24 4/30/202422,140,000 shares $87.45 million +17.0%N/A8.5 $3.95 4/15/202418,920,000 shares $106.71 million +14.7%N/A6.8 $5.64 3/31/202416,490,000 shares $121.04 million +25.3%19.0%5.8 $7.34 3/15/202413,160,000 shares $98.57 million -2.5%15.2%4.6 $7.49 2/29/202413,490,000 shares $95.64 million +1.4%15.6%5.1 $7.09 2/15/202413,310,000 shares $94.23 million +15.9%15.5%5.3 $7.08 1/31/202411,480,000 shares $70.72 million +6.6%12.4%4.7 $6.16 1/15/202410,770,000 shares $49.00 million +2.1%11.6%5.3 $4.55 12/31/202310,550,000 shares $39.46 million -2.1%11.4%5.8 $3.74 12/15/202310,780,000 shares $32.56 million -7.9%11.6%6.3 $3.02 11/30/202311,710,000 shares $29.16 million +0.9%12.6%5.6 $2.49 11/15/202311,610,000 shares $28.79 million -1.6%12.5%5.3 $2.48Your blueprint for crypto wealth (Ad)Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Claim your pass to the Crypto Community Summit here (free for a limited time) 10/31/202311,800,000 shares $21.36 million -14.5%12.7%5.2 $1.81 10/15/202313,800,000 shares $23.46 million -7.4%14.9%6.1 $1.70 9/30/202314,900,000 shares $31.59 million -38.7%16.1%6.6 $2.12 9/15/202324,290,000 shares $53.44 million -12.1%26.2%10.7 $2.20 8/31/202327,640,000 shares $69.38 million -2.3%29.8%12.7 $2.51 8/15/202328,290,000 shares $82.89 million +2.4%30.5%13.2 $2.93 7/31/202327,630,000 shares $114.11 million +7.6%29.9%12.9 $4.13 7/15/202325,670,000 shares $121.42 million -1.0%27.8%11.5 $4.73 6/30/202325,930,000 shares $123.43 million -11.9%28.1%10.6 $4.76 6/15/202329,440,000 shares $171.05 million +1.1%31.9%11.7 $5.81 5/31/202329,120,000 shares $147.06 million 0.0%31.5%11.2 $5.05 5/15/202329,130,000 shares $155.26 million +3.7%31.6%10.8 $5.33 4/30/202328,080,000 shares $170.45 million +4.3%30.7%10.3 $6.07 4/15/202326,920,000 shares $161.79 million -1.5%29.5%9.7 $6.01 3/31/202327,340,000 shares $155.84 million +26.7%30.0%9.1 $5.70 3/15/202321,580,000 shares $119.98 million +15.7%23.6%5.4 $5.56 2/28/202318,660,000 shares $114.20 million +10.7%20.4%5.1 $6.12 2/15/202316,850,000 shares $106.83 million +3.5%18.7%4.9 $6.34 1/31/202316,280,000 shares $97.03 million +5.4%17.8%4.9 $5.96 1/15/202315,450,000 shares $83.43 million -30.8%16.9%4.9 $5.40 12/30/202222,330,000 shares $225.31 million +10.3%24.5%7.8 $10.09 12/15/202220,240,000 shares $287.61 million -4.6%22.2%13.5 $14.21 11/30/202221,220,000 shares $441.80 million -4.1%23.2%16.6 $20.82 11/15/202222,120,000 shares $492.83 million -0.5%24.2%16.8 $22.28 10/31/202222,230,000 shares $465.05 million +2.1%24.4%16.3 $20.92 10/15/202221,780,000 shares $443.44 million +0.7%24.0%16.5 $20.36 9/30/202221,620,000 shares $484.50 million +3.9%23.8%16.5 $22.41 9/15/202220,800,000 shares $562.64 million +2.8%22.9%15 $27.05 8/31/202220,240,000 shares $529.07 million +1.6%22.3%13.6 $26.14 8/15/202219,920,000 shares $718.32 million -5.6%21.9%12.9 $36.06 7/31/202221,100,000 shares $644.18 million -0.6%23.3%13 $30.53 7/15/202221,220,000 shares $672.67 million -3.6%23.4%12.9 $31.70 6/30/202222,010,000 shares $545.41 million +6.8%24.4%13.6 $24.78 6/15/202220,600,000 shares $399.23 million +0.6%36.4%13.1 $19.38 5/31/202220,470,000 shares $472.86 million +14.4%22.6%14.3 $23.10 5/15/202217,900,000 shares $433.54 million +8.2%19.8%12.8 $24.22 4/30/202216,550,000 shares $472.67 million +3.4%18.3%12.9 $28.56 4/15/202216,000,000 shares $604.32 million +3.8%17.8%12.2 $37.77 3/31/202215,420,000 shares $597.83 million -1.7%17.1%11.3 $38.77 3/15/202215,690,000 shares $491.25 million +2.0%17.4%11.5 $31.31 2/28/202215,390,000 shares $531.72 million +11.9%17.1%10.8 $34.55 2/15/202213,760,000 shares $521.23 million +9.6%15.4%10 $37.88 1/31/202212,550,000 shares $520.95 million +7.5%14.0%9.8 $41.51 1/15/202211,670,000 shares $505.08 million +1.6%13.0%9.5 $43.28 12/31/202111,490,000 shares $672.28 million +6.3%12.8%10.2 $58.51 12/15/202110,810,000 shares $590.98 million -0.4%12.0%9.8 $54.67 11/30/202110,850,000 shares $596.86 million +7.0%12.1%11.7 $55.01 11/15/202110,140,000 shares $544.82 million -1.8%11.3%10.9 $53.73 10/29/202110,330,000 shares $555.75 million -3.9%11.6%9.7 $53.80 10/15/202110,750,000 shares $658.33 million -5.7%12.1%10.2 $61.24Your blueprint for crypto wealth (Ad)Mark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Claim your pass to the Crypto Community Summit here (free for a limited time) 9/30/202111,400,000 shares $675.68 million -3.4%12.8%11.4 $59.27 9/15/202111,800,000 shares $784.70 million -1.2%13.2%12 $66.50 8/31/202111,940,000 shares $874.61 million -3.1%13.4%11.6 $73.25 8/13/202112,320,000 shares $1.07 billion +0.8%13.8%12.2 $86.71 7/30/202112,220,000 shares $1.01 billion +5.0%13.7%13 $82.80 7/15/202111,640,000 shares $892.79 million -1.7%13.2%12 $76.70 6/30/202111,840,000 shares $1.03 billion +0.4%13.4%12.1 $86.79 6/15/202111,790,000 shares $1.02 billion -3.1%13.4%11.4 $86.79 5/28/202112,170,000 shares $932.22 million -6.5%13.8%12 $76.60 5/14/202113,020,000 shares $931.06 million +6.5%N/A12.9 $71.51 4/30/202112,230,000 shares $1.05 billion +1.3%N/A12.2 $85.87 4/15/202112,070,000 shares $1.02 billion +0.1%N/A12.3 $84.73 3/31/202112,060,000 shares $893.53 million +4.3%N/A11.6 $74.09 3/15/202111,560,000 shares $1.09 billion +12.2%N/A11.2 $93.99 2/26/202110,300,000 shares $888.58 million +7.0%N/A8.2 $86.27 2/12/20219,630,000 shares $987.08 million -4.5%N/A8 $102.50 1/29/202110,080,000 shares $916.37 million -0.8%N/A8.7 $90.91 1/15/202110,160,000 shares $1.19 billion -8.0%N/A8.9 $117.40 12/31/202011,040,000 shares $1.03 billion -15.6%N/A9.7 $93.62 12/15/202013,080,000 shares $1.26 billion -9.2%N/A12.2 $96.38 11/30/202014,400,000 shares $834.05 million +0.9%N/A13.2 $57.92 11/15/202014,270,000 shares $720.78 million -0.6%N/A16 $50.51 10/30/202014,350,000 shares $654.79 million -3.6%N/A16.7 $45.63 10/15/202014,880,000 shares $698.76 million +7.1%N/A17.4 $46.96 9/30/202013,900,000 shares $555.58 million +7.6%N/A17.2 $39.97 9/15/202012,920,000 shares $485.28 million +1.9%N/A16.2 $37.56 8/31/202012,680,000 shares $461.55 million +2.6%N/A16.2 $36.40 8/14/202012,360,000 shares $425.31 million +1.4%N/A13.6 $34.41 7/31/202012,190,000 shares $381.18 million -0.6%N/A12.1 $31.27 7/15/202012,260,000 shares $427.51 million -1.0%N/A12 $34.87 FATE Short Interest - Frequently Asked Questions What is Fate Therapeutics' current short interest? Short interest is the volume of Fate Therapeutics shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 9,540,000 shares of FATE short. 8.81% of Fate Therapeutics' shares are currently sold short. Learn More on Fate Therapeutics' current short interest. What is a good short interest ratio for Fate Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FATE shares currently have a short interest ratio of 5.0. Learn More on Fate Therapeutics's short interest ratio. Which institutional investors are shorting Fate Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fate Therapeutics: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Fate Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.81% of Fate Therapeutics' floating shares are currently sold short. Is Fate Therapeutics' short interest increasing or decreasing? Fate Therapeutics saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 9,540,000 shares, an increase of 0.3% from the previous total of 9,510,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Fate Therapeutics' short interest compare to its competitors? 8.81% of Fate Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Fate Therapeutics: Siga Technologies Inc. (7.18%), aTyr Pharma, Inc. (21.45%), Precigen, Inc. (19.85%), Mereo BioPharma Group plc - Sponsored ADR (5.46%), Capricor Therapeutics, Inc. (27.32%), Kamada Ltd. (0.45%), Rapport Therapeutics, Inc. (16.26%), Cullinan Therapeutics, Inc. (16.68%), PureTech Health PLC Sponsored ADR (0.02%), Rezolute, Inc. (11.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($72.10 billion), Invesco QQQ ($26.89 billion), iShares Russell 2000 ETF ($19.61 billion), MicroStrategy Incorporated ($9.52 billion), iShares 20+ Year Treasury Bond ETF ($8.70 billion), WD-40 Company ($7.66 billion), Technology Select Sector SPDR Fund ($6.10 billion), Invesco S&P 500 Equal Weight ETF ($5.80 billion), Invesco S&P 500 Top 50 ETF ($5.53 billion), and Vanguard Large-Cap ETF ($5.35 billion). View all of the most shorted stocks. What does it mean to sell short Fate Therapeutics stock? Short selling FATE is an investing strategy that aims to generate trading profit from Fate Therapeutics as its price is falling. FATE shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fate Therapeutics? A short squeeze for Fate Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FATE, which in turn drives the price of the stock up even further. How often is Fate Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FATE, twice per month. The most recent reporting period available is June, 30 2025. More Short Interest Resources from MarketBeat Related Companies SIGA Short Squeeze ATYR Short Squeeze PGEN Short Squeeze MREO Short Squeeze CAPR Short Squeeze KMDA Short Squeeze RAPP Short Squeeze CGEM Short Squeeze PRTC Short Squeeze RZLT Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FATE) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
